Bill Directory

NMC Act

Expressing support for designation of September 2022 as "National Dystonia Awareness Month" and raising awareness and understanding of the disorder of dystonia.

GRIEF Act

BID Act of 2022

Humane Retirement Act

KIDS Health Act of 2022

Reproductive Health Care Accessibility Act

Peer-to-Peer Suicide Prevention Act

End Lockdowns and Vaccine Mandates Act

Of inquiry directing the President to provide certain documents in the President's possession to the House of Representatives relating to the oversight of the Wuhan Institute of Virology laboratory by the Director of the National Institutes of Health.

Of inquiry directing the President to provide certain documents in the President's possession to the House of Representatives relating to the recall of infant formula manufactured by Abbott Laboratories and potential impacts on the infant formula supply chain.

Of inquiry directing the Secretary of Health and Human Services to provide certain documentation to the House of Representatives relating to the negotiation of prices for prescription drugs under the Medicare prescription drug program.

Solutions Not Stigmas Act of 2022

Affordable Rabies Treatment for Uninsured Act

Supporting Our First Responders Act

Updated Drug Labeling for Patient Safety Act

Medicare Advantage Consumer Protection and Transparency Act

Of inquiry requesting the President and directing the Secretary of Health and Human Services to transmit, respectively, certain documents to the House of Representatives relating to ivermectin.

Of inquiry directing the President to provide certain documents in the President's possession to the House of Representatives relating to COVID-19 funding.

Of inquiry directing the President to provide certain documents in the President's possession to the House of Representatives relating to communications by or among any of the Department of Health and Human Services, the Office of National Drug Control Policy, the White House, the Drug Enforcement Administration, and the Department of Justice related to the executive branch's recommendations for a long-term, consensus approach to reduce the supply and availability of illicitly manufactured fentanyl-related substances in the United States.